|
Concordance between HER-2 status determined by qPCR in Fine Needle Aspiration Cytology (FNAC) samples compared with IHC and FISH in Core Needle Biopsy (CNB) or surgical specimens in breast cancer patients |
journalArticle |
2016 |
Rodriguez, C.; Suciu, V.; Poterie, A.; Lacroix, L.; Miran, I.; Boichard, A.; Delaloge, S.; Deneuve, J.; Azoulay, S.; Mathieu, M. C.; Valent, A.; Michiels, S.; Arnedos, M.; Vielh, P. |
|
Compartmental resection of a retroperitoneal sarcoma |
journalArticle |
2019 |
Faron, M.; Cavalcanti, A.; Honore, C. |
|
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation |
journalArticle |
2018 |
Frank, S. J.; Blanchard, P.; Lee, J. J.; Sturgis, E. M.; Kies, M. S.; Machtay, M.; Vikram, B.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Hutcheson, K.; Lai, S.; Busse, P. M.; Lee, N. Y.; Lin, A.; Foote, R. L. |
|
Comparative analysis of durable responders on immune checkpoint inhibitors (ICI) versus other systemic therapies: A meta-analysis of phase III trials |
journalArticle |
2018 |
Pons-Tostivint, Elvire; Latouche, Aurélien; Vaflard, Pauline; Ricci, Francesco; Loirat, Delphine; Sablin, Marie-Paule; Rouzier, Roman; Kamal, Maud; Morel, Claire; Lecerf, Charlotte; Servois, Vincent; Paoletti, Xavier; Le Tourneau, Christophe |
|
Comment on "Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: a Bayesian network meta-analysis", published in Eur J Cancer 51 (2015), 1570-1579 |
journalArticle |
2016 |
Blanchard, P.; Ribassin-Majed, L.; Lee, A.; Pignon, J. P. |
|
Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting |
journalArticle |
2016 |
Martelli, N.; Hansen, P.; van den Brink, H.; Boudard, A.; Cordonnier, A. L.; Devaux, C.; Pineau, J.; Prognon, P.; Borget, I. |
|
Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow |
journalArticle |
2017 |
Blanchard, P.; Menard, C.; Frank, S. J. |
|
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma |
journalArticle |
2016 |
Gunn, G. B.; Blanchard, P.; Garden, A. S.; Zhu, X. R.; Fuller, C. D.; Mohamed, A. S.; Morrison, W. H.; Phan, J.; Beadle, B. M.; Skinner, H. D.; Sturgis, E. M.; Kies, M. S.; Hutcheson, K. A.; Rosenthal, D. I.; Mohan, R.; Gillin, M. T.; Frank, S. J. |
|
Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma |
journalArticle |
2017 |
Bacorro, W.; Escande, A.; Temam, S.; Dumas, I.; Routier, E.; Gensse, M. C.; Blanchard, P.; Janot, F.; Mateus, C.; Tao, Y.; Robert, C.; Deutsch, E.; Haie-Meder, C.; Chargari, C. |
|
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer |
journalArticle |
2019 |
Elhammali, A.; Blanchard, P.; Yoder, A.; Liao, Z.; Zhang, X.; Ronald Zhu, X.; Allen, P. K.; Jeter, M.; Welsh, J.; Nguyen, Q. N. |
|
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma |
journalArticle |
2016 |
Peeler, C. R.; Mirkovic, D.; Titt, U.; Blanchard, P.; Gunther, J. R.; Mahajan, A.; Mohan, R.; Grosshans, D. R. |
|
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis |
journalArticle |
2018 |
Bidard, F. C.; Michiels, S.; Riethdorf, S.; Mueller, V.; Esserman, L. J.; Lucci, A.; Naume, B.; Horiguchi, J.; Gisbert-Criado, R.; Sleijfer, S.; Toi, M.; Garcia-Saenz, J. A.; Hartkopf, A.; Generali, D.; Rothé, F.; Smerage, J.; Muinelo-Romay, L.; Stebbing, J.; Viens, P.; Magbanua, M. J. M.; Hall, C. S.; Engebraaten, O.; Takata, D.; Vidal-Martínez, J.; Onstenk, W.; Fujisawa, N.; Diaz-Rubio, E.; Taran, F. A.; Cappelletti, M. R.; Ignatiadis, M.; Proudhon, C.; Wolf, D. M.; Bauldry, J. B.; Borgen, E.; Nagaoka, R.; Carañana, V.; Kraan, J.; Maestro, M.; Brucker, S. Y.; Weber, K.; Reyal, F.; Amara, D.; Karhade, M. G.; Mathiesen, R. R.; Tokiniwa, H.; Llombart-Cussac, A.; Meddis, A.; Blanche, P.; d''''Hollander, K.; Cottu, P.; Park, J. W.; Loibl, S.; Latouche, A.; Pierga, J. Y.; Pantel, K. |
|
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas |
journalArticle |
2018 |
Delahousse, J.; Verlingue, L.; Broutin, S.; Legoupil, C.; Touat, M.; Doucet, L.; Ammari, S.; Lacroix, L.; Ducreux, M.; Scoazec, J. Y.; Malka, D.; Paci, A.; Hollebecque, A. |
|
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial |
journalArticle |
2016 |
Jovelet, C.; Ileana, E.; Le Deley, M. C.; Motte, N.; Rosellini, S.; Romero, A.; Lefebvre, C.; Pedrero, M.; Pata-Merci, N.; Droin, N.; Deloger, M.; Massard, C.; Hollebecque, A.; Ferte, C.; Boichard, A.; Postel-Vinay, S.; Ngo-Camus, M.; De Baere, T.; Vielh, P.; Scoazec, J. Y.; Vassal, G.; Eggermont, A.; Andre, F.; Soria, J. C.; Lacroix, L. |
|
Choline Positron Emission Tomography/Computed Tomography for Selection of Patients for Salvage Strategies After Primary Local Treatment of Prostate Cancer and Rising Prostate-specific Antigen: Ready for Prime Time? |
journalArticle |
2017 |
Bossi, A.; Mottet, N.; Blanchard, P. |
|
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite |
journalArticle |
2015 |
Grünewald, T. G.; Bernard, V.; Gilardi-Hebenstreit, P.; Raynal, V.; Surdez, D.; Aynaud, M. M.; Mirabeau, O.; Cidre-Aranaz, F.; Tirode, F.; Zaidi, S.; Perot, G.; Jonker, A. H.; Lucchesi, C.; Le Deley, M. C.; Oberlin, O.; Marec-Bérard, P.; Véron, A. S.; Reynaud, S.; Lapouble, E.; Boeva, V.; Rio Frio, T.; Alonso, J.; Bhatia, S.; Pierron, G.; Cancel-Tassin, G.; Cussenot, O.; Cox, D. G.; Morton, L. M.; Machiela, M. J.; Chanock, S. J.; Charnay, P.; Delattre, O. |
|
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies |
journalArticle |
2015 |
Sze, H.; Blanchard, P.; Ng, W. T.; Pignon, J. P.; Lee, A. W. |
|
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis |
journalArticle |
2015 |
Blanchard, P.; Lee, A.; Marguet, S.; Leclercq, J.; Ng, W. T.; Ma, J.; Chan, A. T.; Huang, P. Y.; Benhamou, E.; Zhu, G.; Chua, D. T.; Chen, Y.; Mai, H. Q.; Kwong, D. L.; Cheah, S. L.; Moon, J.; Tung, Y.; Chi, K. H.; Fountzilas, G.; Zhang, L.; Hui, E. P.; Lu, T. X.; Bourhis, J.; Pignon, J. P.; Group, Mac-Npc Collaborative |
|
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia |
journalArticle |
2015 |
Selimoglu-Buet, D.; Wagner-Ballon, O.; Saada, V.; Bardet, V.; Itzykson, R.; Bencheikh, L.; Morabito, M.; Met, E.; Debord, C.; Benayoun, E.; Nloga, A. M.; Fenaux, P.; Braun, T.; Willekens, C.; Quesnel, B.; Ades, L.; Fontenay, M.; Rameau, P.; Droin, N.; Koscielny, S.; Solary, E.; Francophone Myelodysplasia, Group |
|
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies |
journalArticle |
2016 |
Postel-Vinay, S.; Aspeslagh, S.; Lanoy, E.; Robert, C.; Soria, J. C.; Marabelle, A. |
|
Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trials |
journalArticle |
2016 |
Hollebecque, A.; Lanoy, E.; Troallen, F.; Soulat-Dufour, L.; Massard, C.; Bahleda, R.; Varga, A.; Gazzah, A.; Postel-Vinay, S.; Ribrag, V.; Deutsch, E.; Angevin, E.; Boccara, F.; Cohen, A.; Soria, J. C.; Ederhy, S. |
|
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease |
journalArticle |
2016 |
Marthey, L.; Mateus, C.; Mussini, C.; Nachury, M.; Nancey, S.; Grange, F.; Zallot, C.; Peyrin-Biroulet, L.; Rahier, J. F.; Bourdier de Beauregard, M.; Mortier, L.; Coutzac, C.; Soularue, E.; Lanoy, E.; Kapel, N.; Planchard, D.; Chaput, N.; Robert, C.; Carbonnel, F. |
|
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients |
journalArticle |
2019 |
Honore, C.; Delhorme, J. B.; Nassif, E.; Faron, M.; Ferron, G.; Bompas, E.; Glehen, O.; Italiano, A.; Bertucci, F.; Orbach, D.; Pocard, M.; Quenet, F.; Blay, J. Y.; Carrere, S.; Chevreau, C.; Mir, O.; Le Cesne, A. |
|
Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group |
journalArticle |
2016 |
Foulon, S.; Brennan, B.; Gaspar, N.; Dirksen, U.; Jeys, L.; Cassoni, A.; Claude, L.; Seddon, B.; Marec-Berard, P.; Whelan, J.; Paulussen, M.; Streitbuerger, A.; Oberlin, O.; Juergens, H.; Grimer, R.; Le Deley, M. C. |
|
C-Reactive Protein Values After Colorectal Resection: Can We Discharge a Patient With a C-Reactive Protein Value >100? A Retrospective Cohort Study |
journalArticle |
2019 |
Benoit, O.; Faron, M.; Margot, N.; Creavin, B.; Debove, C.; Tiret, E.; Parc, Y.; Lefevre, J. H. |
|
Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution |
journalArticle |
2016 |
Proust-Houdemont, S.; Pasqualini, C.; Blanchard, P.; Dufour, C.; Benhamou, E.; Goma, G.; Semeraro, M.; Raquin, M. A.; Hartmann, O.; Valteau-Couanet, D. |
|
Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration |
journalArticle |
2016 |
Dourthe, M. E.; Ternes, N.; Gajda, D.; Paci, A.; Dufour, C.; Benhamou, E.; Valteau-Couanet, D. |
|
Burnout among young European oncologists: a call for action |
journalArticle |
2017 |
Blanchard, P. |
|
Brachytherapy: An overview for clinicians |
journalArticle |
2019 |
Chargari, C.; Deutsch, E.; Blanchard, P.; Gouy, S.; Martelli, H.; Guerin, F.; Dumas, I.; Bossi, A.; Morice, P.; Viswanathan, A. N.; Haie-Meder, C. |
|
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries |
journalArticle |
2015 |
Cain, L. E.; Phillips, A.; Olson, A.; Sabin, C.; Jose, S.; Justice, A.; Tate, J.; Logan, R.; Robins, J. M.; Sterne, J. A.; van Sighem, A.; Reiss, P.; Young, J.; Fehr, J.; Touloumi, G.; Paparizos, V.; Esteve, A.; Casabona, J.; Monge, S.; Moreno, S.; Seng, R.; Meyer, L.; Pérez-Hoyos, S.; Muga, R.; Dabis, F.; Vandenhende, M. A.; Abgrall, S.; Costagliola, D.; Hernán, M. A. |
|
biospear: an R package for biomarker selection in penalized Cox regression |
journalArticle |
2018 |
Ternes, N.; Rotolo, F.; Michiels, S. |
|
Biomarker Discovery and Validation: Statistical Considerations |
journalArticle |
2021 |
Fang-Shu Ou, PhD,a, Stefan Michiels, PhD,b Yu Shyr, PhD,c Alex A. Adjei, MD, PhD,d Ann L. Oberg, PhD |
|
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis |
journalArticle |
2016 |
Lueza, B.; Rotolo, F.; Bonastre, J.; Pignon, J. P.; Michiels, S. |
|
Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block? |
journalArticle |
2016 |
Ducreux, M.; Pignon, J. P. |
|
Bayesian survival analysis in clinical trials: What methods are used in practice? |
journalArticle |
2017 |
Brard, C.; Le Teuff, G.; Le Deley, M. C.; Hampson, L. V. |
|
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab |
journalArticle |
2017 |
Chaput, N.; Lepage, P.; Coutzac, C.; Soularue, E.; Le Roux, K.; Monot, C.; Boselli, L.; Routier, E.; Cassard, L.; Collins, M.; Vaysse, T.; Marthey, L.; Eggermont, A.; Asvatourian, V.; Lanoy, E.; Mateus, C.; Robert, C.; Carbonnel, F. |
|
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
journalArticle |
2019 |
Matejcic, M.; Saunders, E. J.; Dadaev, T.; Brook, M. N.; Wang, K.; Sheng, X.; Olama, A. A. A.; Schumacher, F. R.; Ingles, S. A.; Govindasami, K.; Benlloch, S.; Berndt, S. I.; Albanes, D.; Koutros, S.; Muir, K.; Stevens, V. L.; Gapstur, S. M.; Tangen, C. M.; Batra, J.; Clements, J.; Gronberg, H.; Pashayan, N.; Schleutker, J.; Wolk, A.; West, C.; Mucci, L.; Kraft, P.; Cancel-Tassin, G.; Sorensen, K. D.; Maehle, L.; Grindedal, E. M.; Strom, S. S.; Neal, D. E.; Hamdy, F. C.; Donovan, J. L.; Travis, R. C.; Hamilton, R. J.; Rosenstein, B.; Lu, Y. J.; Giles, G. G.; Kibel, A. S.; Vega, A.; Bensen, J. T.; Kogevinas, M.; Penney, K. L.; Park, J. Y.; Stanford, J. L.; Cybulski, C.; Nordestgaard, B. G.; Brenner, H.; Maier, C.; Kim, J.; Teixeira, M. R.; Neuhausen, S. L.; De Ruyck, K.; Razack, A.; Newcomb, L. F.; Lessel, D.; Kaneva, R.; Usmani, N.; Claessens, F.; Townsend, P. A.; Gago-Dominguez, M.; Roobol, M. J.; Menegaux, F.; Khaw, K. T.; Cannon-Albright, L. A.; Pandha, H.; Thibodeau, S. N.; Schaid, |
|
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
journalArticle |
2019 |
Schumacher, F. R.; Olama, A. A. A.; Berndt, S. I.; Benlloch, S.; Ahmed, M.; Saunders, E. J.; Dadaev, T.; Leongamornlert, D.; Anokian, E.; Cieza-Borrella, C.; Goh, C.; Brook, M. N.; Sheng, X.; Fachal, L.; Dennis, J.; Tyrer, J.; Muir, K.; Lophatananon, A.; Stevens, V. L.; Gapstur, S. M.; Carter, B. D.; Tangen, C. M.; Goodman, P. J.; Thompson, I. M., Jr.; Batra, J.; Chambers, S.; Moya, L.; Clements, J.; Horvath, L.; Tilley, W.; Risbridger, G. P.; Gronberg, H.; Aly, M.; Nordstrom, T.; Pharoah, P.; Pashayan, N.; Schleutker, J.; Tammela, T. L. J.; Sipeky, C.; Auvinen, A.; Albanes, D.; Weinstein, S.; Wolk, A.; Hakansson, N.; West, C. M. L.; Dunning, A. M.; Burnet, N.; Mucci, L. A.; Giovannucci, E.; Andriole, G. L.; Cussenot, O.; Cancel-Tassin, G.; Koutros, S.; Beane Freeman, L. E.; Sorensen, K. D.; Orntoft, T. F.; Borre, M.; Maehle, L.; Grindedal, E. M.; Neal, D. E.; Donovan, J. L.; Hamdy, F. C.; Martin, R. M.; Travis, R. C.; Key, T. J.; Hamilton, R. J.; Fleshner, N. E.; Finelli, A.; Ingles, |
|
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab |
journalArticle |
2016 |
Hua, C.; Boussemart, L.; Mateus, C.; Routier, E.; Boutros, C.; Cazenave, H.; Viollet, R.; Thomas, M.; Roy, S.; Benannoune, N.; Tomasic, G.; Soria, J. C.; Champiat, S.; Texier, M.; Lanoy, E.; Robert, C. |
|
Assessing head and neck cancer patient preferences and expectations: A systematic review |
journalArticle |
2016 |
Blanchard, P.; Volk, R. J.; Ringash, J.; Peterson, S. K.; Hutcheson, K. A.; Frank, S. J. |